ECIS Cancer incidence estimates (age-standardised rate) (/100k) GLOBOCAN Incidence Rate (age-standardised) (/100k)

Eurostat cancer mortality rate (age-standardised) (/100k) GLOBOCAN Mortality Rate (age-standardized) (/100k) Rank of cancer among causes of deaths (Rank) Potential years of working life lost (/100k) Breast cancer mortality (/100k) Cervical cancer mortality (/100k) Colorectal cancer mortality (/100k) Stomach cancer mortality (/100k) Lung cancer mortality (/100k)

5-year survival rate in esophagus cancer (%) 5-year survival rate in stomach cancer (%) 5-year survival rate in colon cancer (%) 5-year survival rate in rectum cancer (%) 5-year survival rate in liver cancer (%) 5-year survival rate in pancreatic cancer (%) 5-year survival rate in lung cancer (%) 5-year survival rate in melanoma (%) 5-year survival rate in breast cancer (%) 5-year survival rate in cervical cancer (%) 5-year survival rate in ovarian cancer (%) 5-year survival rate in prostate cancer (%) 5-year survival rate in brain cancer (%) 5-year survival rate in myeloid cancers (%) 5-year survival rate in lymphoid cancers (%)

Proportion of daily smokers of cigarettes (%) Cigarette smoking total prevalence (%) Tobacco Control Scale (Score) Relative price level of tobacco (€) Cancer deaths due to tobacco (/100k) Proportion of daily smokers of electronic smoking devices (%) Cancer deaths due to second-hand smoke (/100k)

Alcohol consumption (quantity) - annual (/Lt) Alcohol consumption (frequency) - monthly (%) Heavy drinking rate among adolescents (%) Alcohol harmful use prevalence (%) Cancer cases due to alcohol (/100k) Cancer deaths due to alcohol (/100k) Comprehensive alcohol taxation (yes/no) Minimum alcohol pricing (yes/no) Restrictions on alcohol sales (yes/no) Comprehensive restrictions on alcohol marketing (yes/no) Health warning labels on alcohol (yes/no)

Eurostat Overweight rate (%) WHO Overweight rate (%) Eurostat Obesity rate (%) WHO Obesity rate (%) WHO Childhood obesity rate (%) Cancer deaths due to overweight and obesity (/100k)

Fruit & vegetables consumption (%) Eurostat physical inactivity rate (%) WHO physical inactivity rate (%) Cancer deaths due to dietary risks (/100k) Cancer deaths due to low physical activity (/100k) Front-of-Pack food labelling (yes/no) Health-related food taxes or tariffs (yes/no) Regulation of unhealthy food advertising to children (yes/no) Restrictions on sugar-sweetened beverages in schools (yes/no) Comprehensive nutrition and physical activity health support policy (yes/no)

HPV vaccination coverage among girls (%) HPV vaccination coverage among boys (%) Eligibility for the vaccine (boys, girls, both) (No unit) HPV vaccine registry (yes/no) School-based HPV vaccination programme (yes/no) Primary prevention/HPV Vaccination Index (%)

HepB prevalence (%) HepB immunisation coverage (%) HBV universal childhood vaccination (yes/no) HepC infection rate (%) HepC elimination status (on track Y/N)

Regulation on sunbeds (yes/no) Ban on sunbeds (yes/no) Ban on sunbed unsupervised operation (yes/no) Comprehensive information requirements for sunbed use (yes/no) Comprehensive safety requirements for sunbed use (yes/no)

Air pollution - exposure to PM 2.5 (μg/m3) Air pollution - Cancer deaths due to ambient air pollution (/100k) Air pollution - Cancer deaths due to household air pollution (/100k) Occupation exposure - Cancer deaths due to occupational carcinogens (/100k) Occupational exposure - Cancer deaths due to asbestos (/100k) Radiation exposure - Cancer deaths due to radon (/100k) Radiation exposure - Radon concentration (Bq/m3)

Breast cancer screening rate (%) Organised populated-based breast cancer screening programme (yes/no) Use of recommended age for breast cancer screening programmes (yes/no) Number of dedicated mammography machines (/100k)

Cervical cancer screening rate (%) Organised populated-based cervical cancer screening programme (yes/no) Use of recommended age and test for cervical cancer screening programmes (yes/no) Secondary prevention/Cervical cancer screening Index (%) Availability of HPV self-sampling (yes/no)

Colorectal cancer screening rate (%) Organised populated-based colorectal cancer screening programme (yes/no) Use of recommended age and test for colorectal cancer screening programmes (yes/no)

Organised prostate cancer screening programme (yes/no)

Organised lung cancer screening programme (yes/no)

CT scanners (/100k) MRI units (/100k) PET scanners (/100k)

People who reported to never had had colonoscopy (%)

Single biomarker test access (Low/Medium/High) Reimbursement of single biomarker testing (Low/Medium/High) Multi-biomarker (NGS) test access (Low/Medium/High) Reimbursement of multi-biomarker testing (Low/Medium/High) Biomarker test quality (Low/Medium/High)

Reimbursement status of new oncology medicines (%) Average reimbursement time of new oncology medicines (Days) Uptake of breast cancer medicines (weekly doses) Uptake of colorectal cancer medicines (weekly doses) Uptake of lung cancer medicines (weekly doses) Uptake of prostate cancer medicines (weekly doses) Uptake of melanoma medicines (weekly doses) Uptake of multiple myeloma medicines (weekly doses) Uptake of ovarian cancer medicines (weekly doses) Uptake of immunotherapy medicines (weekly doses)

Radiation therapy equipment (/1Million) Radiation therapy centres (/1Million)

Hospitals beds per 10,000 inhabitants (/10k)

Palliative care services for adults (/100k)

Psycho-oncology support mentioned in NCP (yes/no) Psycho-oncology support with recommendation in NCP (yes/no) Psycho-oncology support with recommendation and indicators in NCP (yes/no)

Legal framework for right to be forgotten in place (yes/no) Number of years that must pass for cancer survivors to have equal access to financial services (/years)

Radiologists (/100k) Pathologists (/100k) Oncologists (/100k) Nurses (/100k) Hematologists (/100k) General practitioners (/100k)

Professional figure of surgical oncologist recognised (yes/no) Cancer nursing education and career development index (Score) Cancer nursing recognition index (Score)

Cancer nursing patient and occupational safety index (Score) Cancer nursing working conditions index (Score)

Unmet need for health care (%)

Total R&D expenditure by the pharmaceutical industry (million €) R&D expenditure by the pharmaceutical industry per capita (€)

Health literacy on cancer prevention/risks (%) Health literacy on cancer symptoms (%) HPV online information availability index (%)

Health care spending on cancer care per capita (not PPP-adjusted) (€) Health care spending on cancer care per capita (PPP-adjusted) (€) Expenditure on cancer drugs per capita (PPP-adjusted) (€) Expenditure on cancer drugs per capita (not PPP-adjusted) (€) Existence of a population-based cancer registry (yes/no) National cancer plan (yes/no)

HPV Prevention Index (%) Cancer nursing index (Score)

Colorectal cancer mortality by age (/100k) Stomach cancer mortality by age (/100k) Lung cancer mortality by age (/100k)

Proportion of daily smokers of cigarettes by age (%) Alcohol consumption (frequency) by age (%) Obesity rate by age (%) Fruit & vegetables consumption by age (%) Physical inactivity by age (%)

Women that reported to have never had breast examination by X-ray by age (%) Women who reported to have never had cervical smear test by age (%) People that reported to have never performed colorectal cancer screening by age (%) People who reported to never had had colonoscopy by age (%)

Proportion of daily smokers of cigarettes per education level (%) Alcohol consumption (frequency) per education level (%) Obesity rate per education level (%) Fruit & vegetables consumption per education level (%) Physical inactivity per education level (%) Proportion of daily smokers of cigarettes per education level (%)

Women that reported to have never had breast examination by X-ray per education level (%) Women who reported to have never had cervical smear test per education level (%) People that reported to have never performed colorectal cancer screening per education level (%)

People who reported to never had had colonoscopy per education level (%)

Proportion of daily smokers of cigarettes per income (%) Alcohol consumption (frequency) per income (%) Obesity rate per income (%) Fruit & vegetables consumption per income (%) Physical inactivity per income (%)

Women that reported to have never had breast examination by X-ray per income (%) Women who reported to have never had cervical smear test per income (%) People that reported to have never performed colorectal cancer screening per income (%)

People who reported to never had had colonoscopy per income (%)

Colorectal cancer mortality by gender (/100k) Stomach cancer mortality by gender (/100k) Lung cancer mortality by gender (/100k)

Proportion of daily smokers of cigarettes by gender (%) Alcohol consumption (quantity) by gender (%) Alcohol consumption (frequency) by gender (%) Obesity rate by gender (%) Fruit & vegetables consumption by gender (%) Physical inactivity by gender (%) Estimated cancer deaths attributable to occupational carcinogens (/100k)

People that reported to have never performed colorectal cancer screening by gender (%)

People who reported to never had had colonoscopy by gender (%)

Percentage of female authors in cancer research (%) Female presence as first author (%) Female presence as last author (%)

Proportion of daily smokers of cigarettes per degree of urbanisation (%) Alcohol consumption (frequency) per degree of urbanisation (%) Obesity rate per degree of urbanisation (%) Fruit & vegetables consumption per degree of urbanisation (%) Physical inactivity per degree of urbanisation (%)

Women that reported to have never had breast examination by X-ray per degree of urbanisation (%) Women who reported to have never had cervical smear test per degree of urbanisation (%) People that reported to have never performed colorectal cancer screening per degree of urbanisation (%)

People who reported to never had had colonoscopy per degree of urbanisation (%)

HepB prevalence among men having sex with men (%)

Trans people who never joined a screening program (%) >50 years old trans people who ever joined a screening program (%)

Oncology health care providers deeming necessary to receive training on trans health needs (%) Oncology health care providers feeling competent in providing assistance to transgender patience (%) Oncology health care providers believing training on healthcare needs should be mandatory (%) Oncology health care providers believing trans people could receive negative reactions from health care professionals (%) Oncology health care providers believing trans people are at risk of discrimination in healthcare (%) Oncology health care providers who have witnessed discriminatory attitudes by colleagues against trans patients (%) Oncology health care providers who declare to be able to establish effective communication with trans patients (%) Oncology health care providers who declare to be comfortable in treating trans patients (%) Oncology health care providers who has treated or followed up trans patients in previous 5 years (%) Oncology health care providers indicating communication with trans patients as sometimes or always difficult (%) Oncology health care providers finding challenging to manage cancer in trans patients (%) Trans people believing their gender identity might have an impact on cancer (%) Trans people declaring only modest satisfaction for health care services (%) Trans people reporting acts of discrimination by health providers (%) Trans people changing specialist after discrimination or openly stating their disappointment (%) Trans patients compelled to treatment discontinuation or renunciation (%) Trans patients indicating lack of knowledge as major reason behind discriminatory behaviour (%) Trans patients indicating lack of experience as major reason behind discriminatory behaviour (%) Trans patients indicating fear and prejudice as major reasons behind discriminatory behaviour (%) Trans patients indicating lack of sensitivity as major reason behind discriminatory behaviour (%) Trans patients indicating lack of appropriate spaces and conditions ensuring privacy as major reason behind discriminatory behaviour (%) Trans patients indicating inability to establish effective communication as major reason behind discriminatory behaviour (%) Oncology health care providers indicating the need for implementing educational resources for healthcare providers (%) Trans patients indicating the need for implementing educational resources for healthcare providers (%) Oncology health care providers indicating the need for implementing national policies to prevent discrimination (%) Trans patients indicating the need for implementing national policies to prevent discrimination (%) Oncology health care providers indicating the need for encouraging health care professional to respect gender identity (%) Trans patients indicating the need for encouraging health care professional to respect gender identity (%) Oncology health care providers indicating the need for including more trans people in clinical trials (%) Oncology health care providers believing initiatives improving trans patients care would improve oncologists communication (%) Oncology health care providers believing initiatives improving trans patients care would allow more ethical treatment (%) Oncology health care providers believing initiatives improving trans patients care would allow for more patient-centric treatment (%) Oncology health care providers believing initiatives improving trans patients care would improve compliance to treatment (%) LGBTIQ+ people who felt discriminated in healthcare (%) Lesbian people who felt discriminated in healthcare (%) Gay people who felt discriminated in healthcare (%) Bisexual (female) people who felt discriminated in healthcare (%) Bisexual (male) people who felt discriminated in healthcare (%) Transgender people who felt discriminated in healthcare (No unit) LGBTIQ+ people who have received inappropriate curiosity or comments in healthcare (%) LGBTIQ+ people who got their specific needs ignored in healthcare (%) LGBTIQ+ people who have foregone treatment for fear of discrimination or intolerant reactions (%)

LGBTIQ+ people who have avoided healthcare services (%) LGBTIQ+ people who had difficulty in gaining access to healthcare (%)

Trans patients indicating the need for including more trans people in clinical trials (%)

Trans individuals not able to find health-related information for trans people (%) Trans people denouncing health trans-specific information as poor (%)

Route to diagnosis - Other (adjusted) (%) Route to diagnosis - Other (crude) (%) Route to diagnosis - Two-week wait (adjusted) (%) Route to diagnosis - Two-week wait (crude) (%) Route to diagnosis - Screen (adjusted) (%) Route to diagnosis - Screen (crude) (%) Route to diagnosis - Hospital (adjusted) (%) Route to diagnosis - Hospital (crude) (%) Route to diagnosis - Elective GP-referral (adjusted) (%) Route to diagnosis - Elective GP-referral (crude) (%) Route to diagnosis - Emergency (adjusted) (%) Route to diagnosis - Emergency (crude) (%)

Prevalence of discrimination in health (%) Self-reported health problem (%) Perception of health (very good / good) (%) Self-reported unmet medical needs (%)

HepB prevalence among migrants (%)

HepB prevalence among people in prison (%) Access to HBV vaccination for people in prison (yes/no)

National hepatitis policy inclusive of people who inject drugs (yes/no) Needle and syringe programme coverage (/person) HepC testing coverage among people who inject drugs (%) Unrestricted access to direct-acting antiviral HCV agents for people who inject drugs (yes/no)